Last reviewed · How we verify
pd-1 and DC-NK cells — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
pd-1 and DC-NK cells (pd-1 and DC-NK cells) — Allife Medical Science and Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| pd-1 and DC-NK cells TARGET | pd-1 and DC-NK cells | Allife Medical Science and Technology Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- pd-1 and DC-NK cells CI watch — RSS
- pd-1 and DC-NK cells CI watch — Atom
- pd-1 and DC-NK cells CI watch — JSON
- pd-1 and DC-NK cells alone — RSS
Cite this brief
Drug Landscape (2026). pd-1 and DC-NK cells — Competitive Intelligence Brief. https://druglandscape.com/ci/pd-1-and-dc-nk-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab